Menopause is a universal and irreversible aspect of the aging process. This study is aiming to evaluate the current knowledge of menopause and Menopausal Hormonal Therapy (MHT) in women in Jeddah city. A community-based study conducted in Jeddah from November 2022 till March 2023. The study enrolled 302 women aged from 35-65 years. A structured validated questionnaire was administered through on-line self-administered questionnaire. “Menopause Knowledge Scale (MKS)”, the menopause symptoms knowledge and MHT practice were used. Linear logistic regression were used to assess the relationship between knowledge scale and independent factors. Data revealed that 11.3% of study samples were prescribed MHT. The most recognized symptoms were mood swings (65.8%). An 82.1% of study sample agree that menopause starts when menstruation ceases. Menopausal state was the sole significant predictor for knowledge and accounts for around 3% in the model (p < 0.005). Participants demonstrated good knowledge of menopause but limited awareness and uptake of menopausal hormonal therapy (MHT). Menopausal status was the only factor significantly associated with knowledge levels. These findings highlight the need to improve awareness of menopausal symptoms and available treatment options. • Most participants showed limited awareness of Menopausal Hormonal Therapy (MHT). • Only 11.3% of women reported being prescribed MHT. • Mood swings were the most recognized menopausal symptom (65.8%). • Menopausal status was the only significant predictor of knowledge.
Alsulami et al. (Sun,) studied this question.